|
NASHVILLE, Tenn.--(BUSINESS WIRE)--May 15, 2003--Renal Care Group, Inc.
(NYSE:RCI - News) today announced that Gary Brukardt has been elected
as a member of the Company's Board of Directors. Mr. Brukardt was named
president and chief executive officer of Renal Care Group in April 2003.
William P. Johnston, chairman of Renal Care Group, commented, "With
the addition of Gary to the Board of Directors, we have further recognized
his leadership of the management team that will guide Renal Care Group
to the next level as a leader in the dialysis services industry."
Mr. Brukardt added, "I am honored to be elected and eager to work
closely with the other Board members toward the attainment of our stated
corporate goals. Our associates are working diligently to provide high
quality care for our patients and excellent financial returns for our
shareholders, and our Board supports and guides them in these efforts."
Renal Care Group, Inc. is a specialized dialysis services company that
provides care to patients with kidney disease. The Company currently treats
over 20,800 patients in more than 270 owned outpatient dialysis facilities,
in addition to providing acute dialysis services at approximately 120
hospitals. Over 6,500 associates provide services across the Company's
27-state network.
Certain statements in this press release, particularly those of Mr. Johnston
and Mr. Brukardt, constitute "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements which are usually preceded by words like expect,
plan, intend, will and the like, include statements regarding our financial
outlook for 2003 and any other statements that necessarily depend on future
events. These forward-looking statements reflect management's expectations
and are based upon currently available information. These forward-looking
statements involve known and unknown risks, uncertainties and other factors
that may cause actual results, performance or achievements of Renal Care
Group to differ materially from those expressed in or implied by the forward-looking
statements, including risks related to: executive succession and dependence
on executive officers; compliance with health care and other applicable
laws; the integration of acquired companies; changes in the Medicare and
Medicaid programs; risks related to the drug Epogen (EPO); payment reductions
by private insurers, hospitals or managed care organizations; and changes
in the health care delivery, financing or reimbursement systems. These
and other factors affecting the Company are discussed in more detail in
Renal Care Group's reports filed with the Securities and Exchange Commission,
including without limitation Renal Care Group's most recent annual report
on Form 10-K and any quarterly reports on Form 10-Q filed after that annual
report. Copies of these filings are available from Renal Care Group upon
request.
Contact:
Renal Care Group, Inc., Nashville
R. Dirk Allison, 615/345-5500
|
Press Releases